Novel Treatment Strategies for Indolent Lymphomas: Oncology Nurse-Centric Discussions

Description
This symposium is designed to provide oncology nurses with an overview of novel treatment strategies for indolent lymphomas with a focus on follicular lymphoma, chronic lymphocytic leukemia, and mantle cell lymphoma. The program will include a historical perspective on the management of indolent lymphomas followed by discussions of novel treatment approaches for newly diagnosed and relapsed/refractory disease. Nursing management strategies to ensure the safety of patients receiving novel therapeutic agents will be presented

Monoclonal Antibody Therapy for Follicular Non-Hodgkin's Lymphomas: Moving Toward a Cure

Description
The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with follicular NHL. In this educational symposium, the principles of antibody-based therapy will be described in 3-D video animation. This presentation will be followed by a historical review of follicular NHL treatment options and the current treatment landscape. An overview of how treatment decisions are made based on prognostic parameters will be given. A case presentation will facilitate discussions on the appropriate nursing management of patients with follicular NHL receiving monoclonal antibody therapy. Oncology nurses' understanding of presented issues and their own practice patterns will be questioned via audience response technology.

Non-Hodgkin’s Lymphomas: Understanding Monoclonal Antibody Therapy

Description
The clinical development of monoclonal antibodies represents a major advancement in the treatment of patients with NHL. In this educational symposium, the principles of antibody-based therapy and its role in the management of NHL will set the stage for a case-based discussion on how to incorporate monoclonal antibodies into treatment strategies for aggressive and indolent B-cell disease. Appropriate nursing management of patients with NHL receiving monoclonal antibody therapy will be highlighted.

Monoclonal Antibodies in Non-Hodgkin's Lymphomas

Description
The use of monoclonal antibodies has been one of the most important advancements in the treatment of B-cell indolent and aggressive NHLs, and much research has been performed in this field. This symposium will include a state-of-the-art discussion on the use of monoclonal antibodies in the treatment of NHLs. Presentations of recent clinical trial data will be followed by a case-based discussion on incorporating these data into treatment decisions.